American Association for Cancer Research

Translation of the Cancer Genome: Scientific, Clinical, and Operational Challenges

Bookmark and Share

Translation of the Cancer Genome.

Translation of the Cancer Genome:
Scientific, Clinical, and Operational Challenges
October 15-18, 2011
Hyatt Regency San Francisco
San Francisco, CA

CONFERENCE CO-CHAIRPERSONS:
Lynda Chin, University of Texas MD Anderson Cancer Center, Houston, TX
Joe W. Gray, Oregon Health and Science University Knight Cancer Institute, Portland, OR
William R. Sellers, Novartis Institutes for BioMedical Research, Cambridge, MA

This conference brought together basic, translational, and clinical scientists from academia and the pharmaceutical industry to discuss and outline effective scientific, clinical, and operational approaches to translate genome discovery to effective biomarkers and therapies. The 2011 program started with an educational session followed by plenary sessions on the biology and genomics of cancer evolution, functional genomics, target validation and biology, defining the clinical path hypothesis, and genomics in clinical trial design. Short talks from highly-rated abstracts were included in many plenary sessions, and a special "Hot Topics" session featured late-breaking research. Keynote talks were presented by Drs. Pier J. Oddone (Fermilab), Douglas Hanahan (Swiss Institute of Experimental Cancer Research), and William R. Sellers (Novartis Institutes for BioMedical Research).

* Adobe Acrobat Reader required

Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.